Browsing Tag
FreeStyle Libre
3 posts
Abbott (ABT) stock surges 12% as Q2 earnings beat lifts 2026 EPS outlook to $5.45-$5.60
Abbott shares headed for their strongest daily gain in 24 years after the healthcare group beat second-quarter expectations and raised its adjusted earnings forecast.
Dangerous glucose monitor readings spark FDA Class I recall: What went wrong with Abbott sensors?
Abbott’s FreeStyle Libre 3 sensors linked to 7 deaths and 700+ injuries. Find out what the FDA warns and what patients should do now.
Why Tandem Diabetes Care’s shift to pharmacy access could fuel its $1bn 2025 target
Tandem Diabetes Care outlines its path to $1 billion in 2025 revenue driven by pharmacy channel expansion, higher recurring revenue and gross margin improvement.